EA200801393A1 - Получение гамма-аминокислот, обладающих аффинностью в отношении альфа-2-дельта белка - Google Patents

Получение гамма-аминокислот, обладающих аффинностью в отношении альфа-2-дельта белка

Info

Publication number
EA200801393A1
EA200801393A1 EA200801393A EA200801393A EA200801393A1 EA 200801393 A1 EA200801393 A1 EA 200801393A1 EA 200801393 A EA200801393 A EA 200801393A EA 200801393 A EA200801393 A EA 200801393A EA 200801393 A1 EA200801393 A1 EA 200801393A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alpha
amino acids
affinding
respect
delta protein
Prior art date
Application number
EA200801393A
Other languages
English (en)
Inventor
Маргарет Клер Эванс
Ллойд Чарльз Франклин
Лоррейн Мишелль Мерта
Томас Норман Наннинга
Брюс Аллен Перлман
Джеймс Эдвард Сэнз
Ниамх Джозефин Уиллис
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200801393A1 publication Critical patent/EA200801393A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Раскрыты материалы и способы получения оптически активных γ-аминокислот формулы (I), которые связываются с альфа-2-дельта (α2δ) субъединицей кальциевого канала.
EA200801393A 2005-12-21 2006-12-11 Получение гамма-аминокислот, обладающих аффинностью в отношении альфа-2-дельта белка EA200801393A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21
PCT/IB2006/003656 WO2007072159A1 (en) 2005-12-21 2006-12-11 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein

Publications (1)

Publication Number Publication Date
EA200801393A1 true EA200801393A1 (ru) 2009-12-30

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801393A EA200801393A1 (ru) 2005-12-21 2006-12-11 Получение гамма-аминокислот, обладающих аффинностью в отношении альфа-2-дельта белка

Country Status (28)

Country Link
US (2) US20070141684A1 (ru)
EP (2) EP2017259A3 (ru)
JP (1) JP2009520492A (ru)
KR (1) KR20080068932A (ru)
CN (1) CN101341117A (ru)
AP (1) AP2008004485A0 (ru)
AR (1) AR058559A1 (ru)
AU (1) AU2006327872A1 (ru)
BR (1) BRPI0620467A2 (ru)
CA (1) CA2633358A1 (ru)
CR (1) CR10080A (ru)
DO (1) DOP2006000286A (ru)
EA (1) EA200801393A1 (ru)
EC (1) ECSP088551A (ru)
GT (1) GT200600524A (ru)
IL (1) IL191840A0 (ru)
MA (1) MA30139B1 (ru)
ME (1) ME00005B (ru)
NL (1) NL2000374C2 (ru)
NO (1) NO20082989L (ru)
NZ (1) NZ568971A (ru)
PE (1) PE20071169A1 (ru)
RS (1) RS20080279A (ru)
TN (1) TNSN08272A1 (ru)
TW (1) TW200736201A (ru)
UY (1) UY30031A1 (ru)
WO (1) WO2007072159A1 (ru)
ZA (1) ZA200804780B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009141362A2 (en) * 2008-05-21 2009-11-26 Sandoz Ag Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
BR112012029647A2 (pt) 2010-05-21 2016-08-02 Chemilia Ab novos derivados de pirimidinas
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
RU2013147417A (ru) 2011-03-24 2015-04-27 Кемилиа Аб Новые производные пиримидина
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (ja) * 2016-03-10 2017-09-14 第一三共株式会社 酵素による光学分割を用いた光学活性吉草酸誘導体の製造方法
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
OA11962A (en) * 1999-06-10 2006-04-17 Warner Lambert Co Mono-and disubstituted 3-propyl gamma-aminobutyricacids.
WO2004054566A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
UA82292C2 (ru) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Способ стереоселективного превращения алифатических динитрилов в цианокарбоновые кислоты (варианты)

Also Published As

Publication number Publication date
JP2009520492A (ja) 2009-05-28
NL2000374A1 (nl) 2007-06-25
MA30139B1 (fr) 2009-01-02
MEP0708A (xx) 2010-02-10
UY30031A1 (es) 2007-07-31
EP2017259A3 (en) 2011-04-13
IL191840A0 (en) 2008-12-29
NO20082989L (no) 2008-09-19
PE20071169A1 (es) 2007-11-30
AU2006327872A1 (en) 2007-06-28
AP2008004485A0 (en) 2008-06-30
EP2017259A2 (en) 2009-01-21
TNSN08272A1 (fr) 2009-10-30
ECSP088551A (es) 2008-07-30
RS20080279A (en) 2009-07-15
EP1973867A1 (en) 2008-10-01
CN101341117A (zh) 2009-01-07
CA2633358A1 (en) 2007-06-28
WO2007072159B1 (en) 2008-08-21
WO2007072159A1 (en) 2007-06-28
TW200736201A (en) 2007-10-01
CR10080A (es) 2008-07-10
US20070141684A1 (en) 2007-06-21
AR058559A1 (es) 2008-02-13
DOP2006000286A (es) 2007-07-31
GT200600524A (es) 2007-12-03
NZ568971A (en) 2010-04-30
ZA200804780B (en) 2009-05-27
BRPI0620467A2 (pt) 2011-11-16
NL2000374C2 (nl) 2010-02-09
KR20080068932A (ko) 2008-07-24
US20090299093A1 (en) 2009-12-03
ME00005B (me) 2010-06-10

Similar Documents

Publication Publication Date Title
EA200801393A1 (ru) Получение гамма-аминокислот, обладающих аффинностью в отношении альфа-2-дельта белка
EA200801427A1 (ru) Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
EA200901376A1 (ru) Молекулы и способы модуляции пропротеинконвертазы субтилизинового/кексинового типа 9(pcsk9)
EA201391632A1 (ru) Аминокислотные последовательности, направленные против il-17a, il-17f и/или il-17a/f, и содержащие их полипептиды
BR112013020259A2 (pt) tratamento de osteoartrite e dores
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
EA201270115A1 (ru) Биологические способы получения адипиновой кислоты
EA201171148A1 (ru) Антитело-антагонист, специфичное для гетеродимера альфа-4-бета-7
EA201270571A1 (ru) Человеческие il-23-антигенсвязывающие белки
EA201300239A1 (ru) Антитела к fap и способы их применения
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
CR20110204A (es) Moleculas de anticuerpo mejoradas
EA201200861A1 (ru) Антагонисты pcsk9
EA200601404A1 (ru) Полиморфные формы агониста gaba
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
EA201391157A1 (ru) Антагонисты pcsk9
EA201300819A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
EA200701592A1 (ru) Композиты и способы их получения и использования
CR10563A (es) Anticuerpos monoclonales ant-il-6 y usos de los mismos
MA32712B1 (fr) Anticorps anti-vegf/anti-ang-2 bispecifique
AR082739A1 (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
EA201400933A1 (ru) Агенты, связывающие склеростин
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
CR9253A (es) Fijacion de la dosificacion de anticuerpos her